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Abstract 
The aim of the study was to compare, over a 10 year period (1991/2001), reported 
changes in people with narcolepsy in terms of (1) life impact of symptoms (2) sleep 
propensity (3) body mass index, and (4) concomitant illnesses.  Also, to document, 
using retrospective report, (5) environmental factors influencing narcolepsy severity, 
and (6) reported time of worst symptom severity following narcolepsy onset. 
In 1991 127 people with diagnosed narcolepsy and cataplexy completed a wide ranging 
questionnaire. In 2001 attempts were made to recontact these participants and 67 were 
traceable.  Of these, 47 people, (18 males, 29 females; mean age 61.76 years, age 
range 31-86 years) returned a revised questionnaire. The reported impact of excessive 
daytime sleepiness (EDS) on the ability to carry out day to day activities showed minor 
increases in severity over the 10 year period in this older narcolepsy sample, and this 
could not be attributed to major changes in medication status.  It is argued that the 
underlying severity of EDS does not increase with time, but rather that the interaction of 
EDS with the aging process increases its detrimental impact.  There was no evidence 
that any narcolepsy symptom became substantially worse with time for most people 
with the disorder. The influence of environmental factors on symptoms was inconsistent 
within the group.   In terms of other health issues, the elevated BMI, stable over time, 
suggested that excess weight may be a trait often associated with narcolepsy, possibly 
linked to hypocretin deficiency.  A high prevalence rate of diabetes was noted in the 
sample. 
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 The need for longitudinal studies of how narcolepsy progresses across the lifespan has 
long been recognised [1]. To our knowledge only one published study [2] presents data 
which follows the same people with narcolepsy over a number of years. Three 36 hour 
polygraphic recordings were conducted at up to 15 year intervals for 8 patients.  They 
reported a worsening of excessive daytime sleepiness (EDS) in three patients and an 
improvement in three. 
 
The early literature contains some general statements on the course of the disorder with 
several clinicians saying narcolepsy remains essentially unchanged once the symptoms 
emerge  [3,4,5,6]. Occasionally anecdotal information is cited, such as reports of a 
worsening of symptoms with age [7]. 
 
More frequently age is investigated as an independent variable within a study.  One 
investigation [8] reported no significant differences between the under and over 40 year 
age groups in terms of life disruption due to symptoms during the day or night, 
medication effectiveness and side effects, or overall psychosocial adjustment.   As in 
people without narcolepsy, nocturnal sleep quality in those with narcolepsy appears to 
decline with age.  Time awake during the night increases with age in narcolepsy and 
also REM episode length declines [2,9].  Nocturnal sleep efficiency has been shown to 
have a more rapid decline in narcolepsy than in the general population [9].  A recent 
study [10] compared age related changes in symptoms in patients older and younger 
than 65 years of age.  They reported no significant differences in EDS between the 
groups but reduced cataplexy in the aged group. 
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 The course of narcolepsy and fluctuations in symptoms have been investigated using 
retrospective report [2].  Forty four percent indicated a peak in EDS across the course of 
their disorder and fluctuations were attributed most to climatic conditions.  Furthermore 
they reported falling asleep more readily when they were in a state of inner tension than 
with mental / emotional steadiness. 
 
In terms of health, people with narcolepsy have an increased association with being 
overweight or obese [11,12] but no studies have considered how their weight may vary 
longitudinally.  There are reports of people with narcolepsy being more prone to also 
having other physical illnesses, in particular diabetes mellitus [13] and other sleep 
disorders [14] and it is expected that the incidence of concomitant illnesses would 
increase with advancing age.  There are numerous reports of a higher incidence of 
depressed mood and depressive symptomatology in people with narcolepsy  [15,16,17] 
but the degree of association with major clinical depression is controversial, as is the 
association between narcolepsy and psychiatric disorders [18,19,20]. 
 
This study set out to investigate the natural history of narcolepsy symptoms and other 
selected health variables.  The main way this was achieved was through a comparison 
of responses, as provided in 1991 and 2001, by a group of participants with narcolepsy.  
The specific issues addressed include comparisons over the 10 year period of; 
• reported life impact of six narcolepsy symptoms  
• sleep propensity  
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• body mass index 
• concomitant illnesses 
In 2001 additional questions were posed that relied on retrospective report and these 
related to 
• environmental factors which altered symptom severity 
• the time of worst symptom severity  
 
Method 
 
Participants, Procedure and Demographics 
In 1991 127 people with diagnosed narcolepsy and cataplexy completed a wide ranging 
questionnaire, the data from which was published [8].  The clinical criteria for inclusion 
in this sample was (a) diagnosis of narcolepsy by a medical specialist and (b) a reported 
clinical history of cataplexy (from minor to severe).  All participants were recruited and 
followed up through the Australian narcolepsy support group (NODSS).  In 2001 it was 
ascertained that of the original 127, no current addresses were available for 50 and 10 
had died.  Thus 67 potential participants received the revised questionnaire package 
and, of these, 42 returned the completed package immediately and a further five 
returned the questionnaire after a follow up phone call (70% response rate). 
 
The sample thus consisted of 47 people, 18 males and 29 females with an age range 
(in 2001) of 31 to 86 years (mean age = 61.766 years, SD = 15.16).  Three quarters of 
the 2001 sample had been diagnosed for at least 15 years.  The age of diagnosis of the 
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sample was as follows: 0-20 years of age = 25%; 21-50 yrs = 66%; 50-70 yrs = 19%. 
The mean age of onset of six different symptoms, as reported by the participants in 
1991 are shown in Table 1. 
 
Table 1: Mean onset age and age range for each narcolepsy symptom 
 
Symptom  Mean Age(years)      Age Range(years) 
 EDS     22   9-52 
Cataplexy    30   2-57 
Sleep Paralysis   29   14-53 
Hallucinations   26   3-61 
Nocturnal Disruption  31   16-59 
Automatic Behaviour  34   14-73 
 
 
 
 
 
 
 
* EDS = excessive daytime sleepiness 
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Comparison of the percentage of participants in different categories of marital and 
employment status in 1991 and 2001 are shown in Table 2. 
Table 2:  Frequency statistics for demographic data in 1991 and 2001 
 
          1991   2001 
Marital Status:   
  -married   31   30 
-divorced   5   7 
-never married  8   6 
-widowed   3   4 
Employment Status: 
  -retired   12   17 
  -full-time   13   11 
  -part-time   7   6 
  -home duties   6   6 
  -sickness pension  5   3 
  -Other    4   4 
 
 
 
 
 
 
 
 
 
 
 
Questionnaires:  
The questionnaire packages that were distributed in 1991 and 2001 consisted of several 
different sections that covered a range of variables.  In most cases participants simply 
responded to closed or open ended questions.  Five point Likert scales were used to 
measure the reported life impact of symptoms where subjects were asked  “To what 
extent does (..symptom) affect you ability to carry out day to day activities?” with 
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response possibilities from “not at all” to “completely”.  Sleep propensity was measured 
using the Epworth Sleepiness Scale [21].   
 
Additional information that was also sought in both years, and will be described in a 
subsequent article on longitudinal changes, included psychosocial adjustment 
(measured using the Psychosocial Adjustment to Illness Scale, PAIS); vocational 
impact, income security, acceptance of the disorder, medication issues and behavioural 
control of symptoms. 
 
The Victoria University Human Experimentation Ethics Committee approved the study. 
 
Data Analysis 
Data was analysed using the SPSS package and where comparisons between 1991 
and 2001 mean values were sought, paired t-tests were used with alpha at 0.05. 
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 Results 
Life impact of symptoms 
In both 1991 and 2001 each person was asked to assess on a 5 point Likert scale the 
extent to which a particular symptom had affected their ability to carry out day-to-day 
activities during the previous two week period.  This was scored such that a higher 
score indicated greater impact. Comparing results across the 10 year period showed 
that a significant difference was found for the impact of excessive daytime sleepiness 
(EDS), with a greater impact in 2001 than 1991 (see Table 3). In contrast the life impact 
of sleep paralysis, hallucinations and automatic behaviour were reduced across the 10 
year period.  There were no significant changes in impact for cataplexy or nocturnal 
sleep disturbance. 
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Table 3: The means, SD and t-test results of the difference between the impact of 
symptoms on the lives of sufferers (last two weeks) in 1991 and 2001.  
 
1991 2001 t df p Change over 
time 
 
Mean SD Mean SD 
 
    
EDS 
 
 
1.28 0.89 1.73 0.76 3.96 1,41 .000 worsens 
Cataplexy 
 
 
2.18 2.01 1.72 1.85 -1.43 1,43 .158 stable 
Sleep 
paralysis 
 
2.66 2.23 1.66 1.94 -3.17 1,44 .003 improves 
Hallucinations 
 
2.47 2.27 1.45 1.73 -3.17 1,43 .003 improves 
Nocturnal 
disruption 
 
2.43 1.66 2.02 1.30 -1.37 1,43 .216 stable 
Automatic 
behaviour 
2.27 1.89 1.40 1.40 -3.19 1,43 .003 improves 
 
In order to explore the extent of individual differences within these mean comparisons 
the 1991 and 2001 ratings of life impact were compared for each individual. Two types 
frequencies  were collated (1) differences of one point (on the 5 point Likert scale) 
indicating a minor change in symptom impact over time, and  (2) differences of two or 
more points , suggesting a more major shift in symptom impact.  These frequencies are 
shown in Figure 1. 
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Improved Symptom Impact       Worse Symptom Impact 
                 
                 
                 
                 
                 
     4  EDS         21
       0                0             
                 
                 
                 
   8    Cataplexy    7      
   7      4        
                 
                 
                 
   7    Sleep   6       
  10     Paralysis 2         
                 
                 
                 
                 
    6   Hallucinations    8      
14       0          
                 
                 
                 
      2 Nocturnal      12    
 12      Sleep  1          
       Disturbance          
                 
                 
                 
                 
   9     Automatic   6       
  10     Behaviour          
                 
                 
                 
                 
                 
  = minor change           
                 
  = major change           
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Figure 1: Frequency with which minor and major changes (see text) in symptom impact 
were noted between 1991 and 2001 for 47 individuals with narcolepsy. 
 
Figure 1 clearly shows that the significant 1991/2001 difference in EDS impact is largely 
a result of nearly half the group reporting minor worsening in the life impact of their 
EDS.  This is in marked contrast to the other symptoms where more considerable 
numbers of people are reporting major improvements in the life impact of the symptoms.  
Thus the significant differences for sleep paralysis, hallucinations and automatic 
behaviour shown in Table 3 result primarily from major symptom impact improvements 
in 10-14 individuals within each symptom. 
 
Post hoc analyses of the number of people who had changed their medication status 
found that this was not an important confounding factor in the significant EDS finding. 
Analyses showed that only 17% of the people who reported greater EDS impact in 2001 
than 1991 had ceased taking stimulant medication between the years 1991 and 2001. 
 
Environmental Factors influencing Narcolepsy Severity: 
In 2001 all participants were asked about the influence of a series of factors on changes 
in the severity of their narcolepsy symptoms. All questions were prefaced with the 
statement,  ”Over the past 10 years, which of the following events do you believe have 
contributed to any changes you have experienced in the severity of your narcolepsy 
symptoms?”  Frequency data are presented in Table 4 below. 
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Table 4: Frequency of different environmental factors changing severity of narcolepsy 
symptoms. 
 Worse No 
change 
Better Not 
applicable 
Medical condition (eg virus, infection, 
head injury, hospitalisation) 
 
11 13 2 19 
Stress due to life events (eg 
bereavement, war, exams, work) 
 
16 17 3 8 
Life cycle events (eg pregnancy, 
puberty, menopause) 
 
11 12 0 21 
Severe disruption to sleep patterns (eg 
shiftwork, stress, other environmental 
factors) 
 
17 11 1 16 
Hot/ humid weather 
 
 
20 14 0 
 
10 
 
 
Where participants found an event applied to them, they were usually evenly divided on 
whether it made their narcolepsy worse or no different, although most people noted that 
severe sleep disruption and hot/humid weather made their symptoms worse.  
Interestingly, three people noted that stress made their symptoms better. 
 
Worst symptom severity period  
 In both 1991 and 2001 participants were asked to nominate the year that each 
symptom was worst or whether the symptom severity had been constant over time.  
There was remarkable consistency in the responses provided in both questionnaires 
and the 2001 data is presented. Where a year was nominated as the worst year for a 
particular symptom, this was compared to the year nominated as the time of onset of 
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that symptom.  Table 5 below shows the frequency of respondents in each category 
where ‘0-2 yrs” indicates the years since symptom onset when a symptom was the 
worst. 
 
 
Table 5: Frequency of indicating particular years since symptom onset as the worst 
years  
 0-2 
yrs 
3-10 
yrs 
10+ 
yrs 
Last 
2 yrs 
Consistent Never 
present 
Can’t 
remember 
EDS 
 
11 2 3 1 22 0 8 
Cataplexy 
 
10 2 1 5 25 0 4 
Sleep 
paralysis 
 
9 1 3 1 11 17 5 
Hallucinations 
 
9 1 5 3 0 24 5 
Nocturnal 
disruption 
12 0 4 8 12 6 5 
Automatic 
behaviour 
12 1 5 1 3 13 12 
 
For the four classic symptoms of narcolepsy (EDS, cataplexy, sleep paralysis and 
hallucinations) approximately half the sample reported that the severity of the symptoms 
were consistent since their onset.  About a fifth ((18-24%) reported that the worst period 
was within two years of symptom onset.  While a smaller minority said that their 
nocturnal sleep disruption (17%) and cataplexy (11%) was worst in the last 2 years 
there was no overall pattern suggesting increased severity with time for most of the 
sample.  However, these individual differences are considerable enough to suggest that 
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the course of narcolepsy is a heterogenous phenomenon across the sample with some 
people experiencing peaks in severity. 
 
The raw data was further analysed to determine whether it was also the same group of 
people with narcolepsy who experienced the first two years as the worst for different 
symptoms and no such pattern was evident. 
 
Body Mass Index 
Body mass index was calculated from the reported height and weight measures 
provided in both 1991 and 2001 and then categorised as underweight, normal, 
overweight and obese [22].  The frequencies within each category did not change 
substantially between 1991 and 2001 (see Table 6) and a paired t-test confirmed no 
significant change in BMI values over the 10 year period  (1991 mean = 3.18(SD=0.78); 
2001 mean = 3.26(0.74), t(1,43)=1.15, p>.05). 
 
Table 6: Frequency (and percentage) statistics for BMI categories in 2001 and 1991 
 
Condition   Frequency(%) 1991   Frequency(%) 2001 
 
Underweight  1 (2%)    1 (2%) 
Normal    5 (11%)    7 (15%) 
Overweight   19 (40%)    21 (45%) 
Obese    22 (47%)    18 (38%) 
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Concomitant Illnesses 
An open ended question invited documentation of other illnesses.  It was found that the 
reported presence of concomitant illness was greater in 2001 than 1991.  While one 
quarter had no other illness in 1991, after 10 years only one half of the group reported 
such health.  Table 7 summarises the frequencies within the major reported illness 
groups. The high prevalence of diabetes is particularly noteworthy. 
 
Table 7: Frequency statistics for the prevalence of concomitant illnesses in 1991 and 
2001   
 
Condition    1991    2001  
 No other illnesses   36     24  
Cardiovascular   4     6   
Diabetes     2     5  
Musculoskeletal   2     4  
Mental Illness   2     4  
Other Sleep Disorders  0     2  
Respiratory    2    1  
Visual     0     1  
Alcoholism    1     0 
 
Discussion 
Symptoms 
Interestingly, EDS was found to have a greater short-term impact on life activities in 
2001 than 1991, in this older aged sample of people with narcolepsy. This detrimental 
change in symptoms stands alone among the other data that indicated either reduced 
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symptom impact or no change over the 10 year period.  There are several possible 
interpretations: 
• That, taken as a group, there is no change in narcolepsy severity over the 10 year 
period and the worsening life impact of EDS can be attributed to age-related 
changes in sleep-wake patterns interacting with EDS.  These changes lead to a 
reported greater impact of sleepiness on day to day activities when the person gets 
older.  The assumption is that many older people (with or without narcolepsy) make 
more room for sleep/napping in their lives and that this is independent of an 
underlying increase in sleep propensity.  In support of this assumption is the fact that 
there are no reports of ESS increasing with age in normal populations.   A study of 
528 adults aged from their 30s to late 60s found that age was not a predictor of 
Epworth Sleepiness Score (ESS score) [23]. A similar conclusion was drawn from an 
investigation of 1560 elderly WW2 veterans [24].  The employment data indicates 
that a minority of the group were in fulltime employment at both time points of the 
study (27% in 1991 and 23% in 2001), suggesting that most of the sample follow a 
lifestyle where they can choose the pace for most, if not all, the time.  In these 
circumstances people may make more opportunities to sleep as they get older, even 
though their underlying propensity to doze while engaged in another activity (ESS) 
may not have increased.   The finding that all the ratings of increased EDS impact 
with time were minor rather than major, further supports this interpretation. 
• Alternatively, perhaps the greater impact of EDS in 2001 may result from the older 
sample ingesting less stimulant medication because their lifestyle is less demanding 
now than in 1991 or they have more difficulty with side effects. While the data 
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showed that only 17% of those people who reported more impact in 2001 than 1991 
ceased their stimulant medication, what is not known is how many may have 
substantially reduced their daily stimulant intake.  Medication issues may thus play a 
secondary role in the EDS finding. 
• A different interpretation of the data may be that the narcolepsy symptom of EDS 
has worsened over the 10 year period and the measure of sleep propensity (ESS) is 
not sufficiently sensitive in these circumstances to document this.  Some support for 
this interpretation is provided by the study [25] comparing the Maintenance of 
Wakefulness Test (MWT) with the ESS.  Using modelling techniques on the data 
sample of 522 people with narcolepsy, they found that as the MWT level of severe 
sleepiness increased, the ESS remained stable.  Arguing against this explanation of 
the present data are the retrospective reports which found no suggestion that any 
symptom of narcolepsy gets worse for most people.  In fact only one person in the 
sample felt their EDS was at its worst during the last two years.  For the EDS 
symptom, as for the other narcolepsy symptoms, the worst period was either when 
the symptoms first appeared or, more typically, were consistent over time. 
 
Consideration of all the available information, leads most strongly to the interpretation 
that the reported increase of EDS impact on daily activities is a consequence of the 
narcolepsy EDS interacting with age-related changes in sleep wake behaviour and that 
the underlying severity of  any symptom of narcolepsy does not increase over time.  
Reduction in medication may have partially contributed to increased EDS impact. 
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It would appear that the main trend within the sample is that if symptom impact 
becomes worse with time it does so in a fairly minor way, whereas if a symptom 
improves for a person, the improvement is usually quite substantial.  This is consistent 
with the major patterns evident in people’s self report of the worst year for a symptom 
since symptom onset, with very few citing the most recent years as the worst.  
However, clearly individual differences are important in the course of narcolepsy.  
 
The influence of the different environment factors was quite variable across the sample 
with numbers typically evenly divided between factors making their symptoms worse or 
no change with a minority reporting improvement with some events.  The question 
arises as to whether this variability in the sample is due to  
• the differences in the nature of the factors experienced – for example four options 
are listed under “Stress due to life events - bereavement, war, exams, work”,  and 
each of  these may affect people differently and created ambiguity in the 
responses;  
• people’s individual differences; or  
• the possibility that narcolepsy itself is not homogenous but represents a  
heterogenous syndrome encompassing a series of etiologically different disorders.   
 
Health 
An increased body mass index (BMI) was found in this sample of people with 
narcolepsy and this is consistent with many other reports [11,12].  While the present 
study found 86% were overweight or obese (in 2001), the percentage across the 
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Australian population for these BMI categories is 51.8% for females and 67.3% for 
males [26].  No major increase in the proportion of overweight or obese people across 
the 10 year period was noted. This supports the case that elevated BMIs in narcolepsy 
are not secondary to behavioural consequences of the disorder but may be a trait 
characteristic, possibly associated with hypocretin deficiency [27].  An increased 
appetite in narcolepsy is supported by a study of dietary intake which reported an 
increased frequency of snacking and sweet consumption, and a higher overall food 
intake in people with narcolepsy compared to age matched controls. Results also 
suggested that it was not simply the case that the more overweight people ate more 
snacks but that narcolepsy itself was the critical factor [11]. 
 
Advancing age was associated with an increase in the prevalence of concomitant 
illnesses in the sample.  The reported prevalence rate of cardiovascular disorders in 
2001 of 13% is in line with the Australian rate of 16% [28]. However, a rate of 11% for 
diabetes (type not specified) in 2001 for the people with narcolepsy is higher than the 
prevalence rate of diabetes in Australia which is 7.2% of the population over 25 (this 
rate includes people previously undiagnosed) [26].  As epidemiologists estimate that 
approximately one half of the people with diabetes are currently undiagnosed, the true 
rate of diabetes among the narcolepsy sample may be higher than 11%.  Comparison of 
prevalence rates must be done with caution as the most predominant type of diabetes 
(type 2) is an illness that expresses itself more in later life and this narcolepsy cohort is 
predominately older.  However, the current finding is consistent with the conclusion of 
Honda and colleagues [13]  that there is had an increased association between 
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narcolepsy and diabetes mellitus.  While they concluded that the diabetes was 
independent of obesity in their narcolepsy patients, the close association between 
diabetes and excess weight [29] in the normal population suggests this association  
warrants further investigation in narcolepsy. 
 
The low reported frequencies of both mental illness and other sleep disorders is 
surprising and at variance with reports in the literature, where higher rates of mental 
illness and other sleep disorders among people with narcolepsy are documented 
[14,18,19,20].  Perhaps the open-ended nature of the responses in this section on 
illnesses led to some under reporting.  With regard to mental illnesses, those with 
problems in this area may be less likely to return the lengthy questionnaire or have 
traceable home addresses after 10 years. 
 
Conclusions: The reported impact of EDS on the ability to carry out day to day 
activities was greater in 2001 than 1991 in this older narcolepsy sample, and this could 
not be attributed to major changes in medication status.  While nearly half the group 
reported increased impact, in all these individuals this change was reported as minor.  
Interestingly, sleep propensity did not change over time. While various explanations of 
the EDS finding are possible it is argued that the underlying severity of the narcolepsy 
symptom has not increased with time, but rather that the interaction of EDS with the 
aging process increases the detrimental impact of EDS.  
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In contrast, the life impact of sleep paralysis, hallucinations and automatic behaviour 
was reduced over the 10 year period. Both longitudinal evaluations and retrospective 
reports provided no evidence that narcolepsy symptoms became substantially worse 
with time and for many people the impact of the non-EDS symptoms of narcolepsy was 
associated with major improvements. The influence of environmental factors on 
symptoms was inconsistent within the group.   
 
In terms of other health issues, the elevated BMI, stable over time, was felt to suggest 
that excess weight may be a trait often associated with narcolepsy.  A high prevalence 
rate of diabetes was noted and warrants further investigation in narcolepsy populations. 
 
 21
References 
 
[1] Kupfer DJ, Reynolds CF 3rd. A critical review of sleep and its disorders from a 
developmental perspective. Psychiatr Dev 1983;1(4):367-386. 
 
[2] Billiard M, Besset A, Cadilhac J. The clinical and polygraphic development of 
narcolepsy. In: Guilleminault C, Lugaresi E, editors. Sleep/wake disorders: natural 
history, epidemiology, and long-term evolution, New York: Raven Press, 1983. 
 
[3] Yoss RE, Daly DD. On the treatment of narcolepsy. Med Clin North Am 
1968;52:781-787. 
 
[4] Zarcone V. Narcolepsy. N Engl J Med 1973;288:1156-1166. 
 
[5] Roth B. Narcolepsy and hypersomnia. Avicenum. Czechoslavak Medical Press, 
1980,Prague. 
 
[6] Kales A, Cadieux RJ, Soldatos, CR, Bixler ED, Schweitzer PK, Prey WT, Vela-
Bueno A. Narcolepsy-cataplexy, I. Clinical and electrophysiologic characteristics. 
Arch Neurol 1982;39:164-168. 
 
[7] Alaia SL.  Life effects of narcolepsy: measures of negative impact, social support, 
and psychological well-being. Loss Grief Care 1992;5(3/4):1-22. 
 
[8] Bruck D. The impact of narcolepsy on psychological health and role behaviours; 
negative effects and comparisons with other illness groups. Sleep Medicine 2, 
2001;437-446. 
 
[9] Chadhary BA, Husain I. Narcolepsy. Journal of Family Practice. 1993;36(2):207-
214. 
 
[10] Furuta H, Thorpy MJ, Temple HM. Comparison in symptoms between aged and 
younger patients with narcolepsy. Psychiatry Clin Neurosci 2001;55(3):241-242. 
 
[11] Bruck D, Armstrong S, Coleman G. Dietary factors in narcolepsy. Sleep 1989;131-
134. 
 
[12] Dahmen N, Bierbrauer J, Kasten M. Increased prevalence of obesity in narcoleptic 
patients and relatives. Eur Arch Psychiatry Clin Neurosci 2001;251(2):85-89. 
 
[13] Honda Y, Doi Y, Ninomiya R, Ninomiya C. Increased frequency of non-insulin-
dependent diabetes mellitus among narcoleptic patients. Sleep 1986;9(2):254-
259. 
 
[14] Harsh J, Peszka J, Hartwig, G, Mitler M. Night-time sleep and daytime sleepiness 
in narcolepsy. J Sleep Res 2000;9(3):309-316. 
 22
 
[15] Mosko S, Zetin M, Glen S, et al. Self-reported depressive symptomatology, mood 
ratings, and treatment outcome in sleep disorders patients. J Clin Psychol 
1989;45(1):51-60. 
 
[16] Merrit SL, Cohen FT, Smith KM. Depressive symptomatology in narcolepsy. Loss, 
Grief and Care 1992;5(3/4):53-60. 
 
[17] Daniels E, King MA, Smith IE, Shneerson JM.  Health-related quality of life in 
narcolepsy. J Sleep Res 2001;10(1):75-81. 
 
[18] Krishnan RR, Volow MR, Miller PP, Carwile ST.  Narcolepsy: preliminary study of 
psychiatric and psychosocial aspects. Am J Psychiatry 1984;141(3):428-431. 
 
[19] Roy A. Psychiatric aspects of narcolepsy. Br J Psychiatry 1976;128:562-565. 
[20] Wilcox J. Psychopathology and narcolepsy. Neuropsychbiology 1985;14(4):170-
172. 
 
[21] Johns MW. A new method for measuring daytime sleepiness: the Epworth 
sleepiness scale. Sleep 1991;14(6):540-545. 
 
[22] Baylor College of Medicine 2000. Adult height and weight obesity chart: Children’s 
Nutrition Research Centre Publication. Houston Texas. Retrieved Jul 9, 2001 from 
the World Wide Web. 
http://www.bcm.tmc.edu/body/complab/Applicatoins/adultbmichart.htm. 
 
[23] Stradling JR, Barbour C, Glennon J, et al. Prevalence of sleepiness and its 
relation to autonomic evidence of arousals and increased inspiratory effort in a 
community based population of men and women. J Sleep Res 2000;9(4):381-388. 
 
[24] Carmelli D, Bliwise DL, Swan GE, Reed T. A genetic analysis of the Epworth 
Sleepiness Scale in 1560 World War II male veteran twins in the NAS-NRC twin 
registry. J Sleep Res 2001;10(1):53-58. 
 
[25] Sangal RB, Mitler MM, Sangal JM. Subjective sleepiness ratings (Epworth 
sleepiness scale) do not reflect the same parameter of sleepiness as objective 
sleepiness (maintenance of wakefulness test) in patients with narcolepsy. Clin 
Neurophysiol 1999;110(12):2131-2135. 
 
[26] Australian Diabetes, Obesity and Lifestyle Study 2000. Retrieved February 4, 
2002 from the World Wide Web. 
http://www.idi.org.au/downloads/ausdiab%20peliminary%20results%20media%20r
elease.doc. 
 
 23
[27] Overeem S, Mignot E, Gert van Dijk J, Manners GJ. Narcolepsy: clinical features, 
new pathophysiologic insights, and future perspectives. J Clin Neurophysiol 
2001;18(2):78-105. 
 
[28] National Health Survey (ABS catalogue No 4364.0) 1995. Retrieved January 31, 
2002 from the World Wide Web.  http://www.abs.gov.au/ausstats. 
 
 
 
 
 
 
 24
